An open access journal
Rare Diseases Research: Challenges and Progress in Understanding Orphan Diseases
Abstract
Rare diseases, often referred to as orphan diseases, pose significant challenges due to their low prevalence and limited understanding. This paper explores the landscape of rare diseases research, focusing on the unique challenges faced by patients, clinicians, and researchers. Key topics include the definition and classification of rare diseases, the role of genetic and genomic technologies in diagnosis and treatment, and the importance of patient registries and collaborative networks in advancing rare diseases research. Additionally, the paper discusses recent progress in orphan drug development, regulatory incentives for orphan drug approval, and the ethical considerations surrounding patient access to orphan therapies. Furthermore, the paper examines the impact of rare diseases on healthcare systems and society as a whole, emphasizing the need for innovative approaches to diagnosis, treatment, and patient care. By synthesizing insights from interdisciplinary perspectives, this paper aims to raise awareness of rare diseases and foster collaboration to address unmet medical needs in this challenging domain.
Share and Cite
Article Metrics
References
- Austin, C. P., et al. (2018). Future of rare diseases research 2017-2027: an IRDiRC perspective. Clinical and Translational Science, 11(1), 21-27.
- Boycott, K. M., et al. (2017). International cooperation to enable the diagnosis of all rare genetic diseases. American Journal of Human Genetics, 100(5), 695-705.
- Schieppati, A., et al. (2008). Rare diseases and orphan drugs. New England Journal of Medicine, 359(4), 425-438.
- Katsanis, S. H., & Katsanis, N. (2013). Molecular genetic testing and the future of clinical genomics. Nature Reviews Genetics, 14(6), 415-426.
- Kodra, Y., et al. (2017). Recommendations for improving the quality of rare disease registries. International Journal of Environmental Research and Public Health, 14(5), 1-17.
- Terry, S. F., et al. (2016). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565-574.
- Jaffe, A., et al. (2014). The challenges of clinical trials in rare diseases. PLoS Medicine, 11(7), e1001711.
- Rath, A., et al. (2012). Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Human Mutation, 33(5), 803-808.